Medication info
Tenetin M Controlled-release Tablet 10/750 mg

Tenetin M Controlled-release Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Daewoong Pharmaceutical Co., Ltd.
Appearance
Yellow, egg-shaped controlled-release film-coated tablet
Packaging
Bottle - 30 tablets/bottle
Approval status
Active

MFDS item code 202201331 · Approved 2022.04.04 · Insurance code 671807430

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse effects associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be monitored closely and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Since such a change may cause changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Daewoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling blood sugar levels while managing diet and exercise. The combination of teneligliptin and metformin effectively lowers blood sugar, aiding in diabetes management. Regular use stabilizes blood sugar levels and positively impacts the prevention of complications. This medication helps to maintain healthy blood sugar and improve diabetes treatment.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse effects associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be monitored closely and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Since such a change may cause changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used for diabetes treatment and has the effect of lowering blood sugar. However, it may rarely cause a serious metabolic complication known as lactic acidosis, requiring caution. Lactic acidosis is particularly dangerous in patients with decreased kidney function, heart disease, sepsis, etc. This medication should not be administered to patients with moderate to severe renal impairment or severe heart failure. Additionally, this medication should be temporarily discontinued before and after tests using radiologic contrast agents and restarted only after confirming normal kidney function. It is also safe not to use this medication during pregnancy or for women who may become pregnant, patients with significantly impaired liver function, severe infections, or trauma. This medication may increase the risk of hypoglycemia when combined with other diabetes medications, so it is essential to be aware of hypoglycemia symptoms and management methods. Patients should regularly monitor kidney and liver functions and check vitamin B12 levels regularly during treatment. If sudden abdominal pain, vomiting, difficulty breathing, muscle pain, or fatigue occurs during use, consult a doctor immediately. The risk of lactic acidosis increases when taken with alcohol; therefore, it is advisable to avoid alcoholic beverages. Elderly patients or those with compromised kidney function particularly require dosage adjustments and regular monitoring. Patients about to undergo surgery should discontinue this medication 48 hours before surgery and restart it only after confirming normal kidney function post-surgery. This medication has not been proven safe and effective in children or adolescents, so it should not be used in these populations. Moreover, while taking this medication, if severe joint pain or skin blisters occur, inform healthcare personnel immediately. Store this medication out of the reach of children, and be cautious as transferring it to another container may alter its quality.

Side effects

  • Severe lactic acidosis
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • dermatitis herpetiformis
  • acute pancreatitis
  • dizziness
  • abdominal distension
Show 111 more
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • elevated amylase
  • elevated lipase
  • increased AST (GOT)
  • increased ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • increased CK (CPK)
  • elevated serum potassium levels
  • fatigue
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • shingles
  • limb pain
  • upper abdominal pain
  • gastric inflammation
  • upper respiratory infection
  • headache
  • dyspepsia
  • chronic gastritis
  • irritable bowel syndrome
  • viral upper respiratory infection
  • fatigue
  • tremors
  • weakness
  • hunger
  • facial edema
  • nausea
  • cold sweat
  • diabetic retinopathy
  • vision decrease
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • abnormal blood sugar
  • increased blood sugar
  • elevated blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • spinal disc protrusion
  • spinal disc disorders
  • spinal ligament ossification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral calculosis
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastric inflammation
  • bile duct obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • pelvic artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • nasopharyngitis
  • bone fracture
  • diarrhea
  • nausea
  • vomiting
  • reduced serum vitamin B12
  • severe and disabling arthralgia
  • blistering dermatitis herpetiformis
  • pressure ulcer
  • uterine abscess
  • musculoskeletal chest pain
  • spinal disc degeneration
  • hypercholesterolemia
  • falls
  • animal bites
  • radial bone fracture
  • diabetic neuropathy
  • spinal brainstem insufficiency
  • chronic bronchitis
  • enlarged nasal turbinates
  • arteriosclerosis
  • hypertension
  • hearing loss
  • endolymphatic hydrops

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress and kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage maintains the efficacy of the medication and prevents degradation.

Appearance and packaging

Appearance

Yellow, egg-shaped controlled-release film-coated tablet

Package unit

Bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.